Table 2. Goblet cell morphology in DSS + TNF-α neutralizing antibody treated group in comparison to only DSS treatment.
Groups | Percentage of total goblet cells | |||
Filled | Releasing Mucus | Empty | ||
Day 2 | DSS only | 77.4±3.6 | 16.5±1.2 | 6.1±0.6 |
DSS + anti-TNF-α | 67.9±1.2 | 22±0.7 | 10.1±0.5 | |
Day 5 | DSS only | 37.1±0.9 | 22.6±0.5 | 40.2±0.7 |
DSS + anti-TNF-α | 59.6±1.3* | 22.8±0.7 | 29.4±1.6* | |
Day 9 | DSS only | ND | ND | ND |
DSS + anti-TNF-α | 19.6±0.4 | 21.6±0.3 | 58.8±1.0 |
Data are presented as % of goblet cells ± SEM. *P<0.05 when compared to DSS treated group of the respective day. Goblet cell morphology was quantified from randomly selected crypts of PAS stained sections. A minimum number of 100 (100–110) goblet cells were counted under 40 X magnification from each section. Only in the DSS + anti-TNFα treated group we were able to count 51 goblet cells. Goblet cell morphology was designated as previously described [28]. Filled goblet cells: goblet cells with intact mucus granules; Releasing mucus: cells releasing mucus with PAS-stained mucus emerging as a thick stream; Empty goblet cells with PAS stained mucus absent from cells exhibiting a deep concave cavitation of the apical surface. ND: Not determined as the epithelial layer and crypts on day 9 of DSS treatment was destroyed or too damaged in the ulcerated site.